Cargando…

Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies

We have developed a novel real‐time quaking‐induced conversion RT‐QuIC‐based assay to detect alpha‐synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha‐synuclein aggregation in Dementia with Lewy bodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fairfoul, Graham, McGuire, Lynne I., Pal, Suvankar, Ironside, James W., Neumann, Juliane, Christie, Sharon, Joachim, Catherine, Esiri, Margaret, Evetts, Samuel G., Rolinski, Michal, Baig, Fahd, Ruffmann, Claudio, Wade‐Martins, Richard, Hu, Michele T. M., Parkkinen, Laura, Green, Alison J. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048391/
https://www.ncbi.nlm.nih.gov/pubmed/27752516
http://dx.doi.org/10.1002/acn3.338
_version_ 1782457580179685376
author Fairfoul, Graham
McGuire, Lynne I.
Pal, Suvankar
Ironside, James W.
Neumann, Juliane
Christie, Sharon
Joachim, Catherine
Esiri, Margaret
Evetts, Samuel G.
Rolinski, Michal
Baig, Fahd
Ruffmann, Claudio
Wade‐Martins, Richard
Hu, Michele T. M.
Parkkinen, Laura
Green, Alison J. E.
author_facet Fairfoul, Graham
McGuire, Lynne I.
Pal, Suvankar
Ironside, James W.
Neumann, Juliane
Christie, Sharon
Joachim, Catherine
Esiri, Margaret
Evetts, Samuel G.
Rolinski, Michal
Baig, Fahd
Ruffmann, Claudio
Wade‐Martins, Richard
Hu, Michele T. M.
Parkkinen, Laura
Green, Alison J. E.
author_sort Fairfoul, Graham
collection PubMed
description We have developed a novel real‐time quaking‐induced conversion RT‐QuIC‐based assay to detect alpha‐synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha‐synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT‐QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha‐synucleinopathies.
format Online
Article
Text
id pubmed-5048391
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50483912016-10-17 Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies Fairfoul, Graham McGuire, Lynne I. Pal, Suvankar Ironside, James W. Neumann, Juliane Christie, Sharon Joachim, Catherine Esiri, Margaret Evetts, Samuel G. Rolinski, Michal Baig, Fahd Ruffmann, Claudio Wade‐Martins, Richard Hu, Michele T. M. Parkkinen, Laura Green, Alison J. E. Ann Clin Transl Neurol Brief Communications We have developed a novel real‐time quaking‐induced conversion RT‐QuIC‐based assay to detect alpha‐synuclein aggregation in brain and cerebrospinal fluid from dementia with Lewy bodies and Parkinson's disease patients. This assay can detect alpha‐synuclein aggregation in Dementia with Lewy bodies and Parkinson's disease cerebrospinal fluid with sensitivities of 92% and 95%, respectively, and with an overall specificity of 100% when compared to Alzheimer and control cerebrospinal fluid. Patients with neuropathologically confirmed tauopathies (progressive supranuclear palsy; corticobasal degeneration) gave negative results. These results suggest that RT‐QuiC analysis of cerebrospinal fluid is potentially useful for the early clinical assessment of patients with alpha‐synucleinopathies. John Wiley and Sons Inc. 2016-08-28 /pmc/articles/PMC5048391/ /pubmed/27752516 http://dx.doi.org/10.1002/acn3.338 Text en © 2016 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communications
Fairfoul, Graham
McGuire, Lynne I.
Pal, Suvankar
Ironside, James W.
Neumann, Juliane
Christie, Sharon
Joachim, Catherine
Esiri, Margaret
Evetts, Samuel G.
Rolinski, Michal
Baig, Fahd
Ruffmann, Claudio
Wade‐Martins, Richard
Hu, Michele T. M.
Parkkinen, Laura
Green, Alison J. E.
Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title_full Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title_fullStr Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title_full_unstemmed Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title_short Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
title_sort alpha‐synuclein rt‐quic in the csf of patients with alpha‐synucleinopathies
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048391/
https://www.ncbi.nlm.nih.gov/pubmed/27752516
http://dx.doi.org/10.1002/acn3.338
work_keys_str_mv AT fairfoulgraham alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT mcguirelynnei alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT palsuvankar alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT ironsidejamesw alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT neumannjuliane alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT christiesharon alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT joachimcatherine alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT esirimargaret alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT evettssamuelg alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT rolinskimichal alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT baigfahd alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT ruffmannclaudio alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT wademartinsrichard alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT humicheletm alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT parkkinenlaura alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies
AT greenalisonje alphasynucleinrtquicinthecsfofpatientswithalphasynucleinopathies